Dynavax Technologies (DVAX)

$11.21 0.05 (0.44%)

16:00 EDT DVAX Stock Quote Delayed 30 Minutes

DVAX Stock Earnings: Dynavax Technologies Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings Aug 6, 2024

DVAX stock results show that Dynavax Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

DVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024

The 7 Best Stocks Under $15 to Buy in June 2023

7 Biotech Stocks Sitting in the Sweet Spot

Volume:

Previous Close -

Market Cap 1.44B

PE Ratio 101.91

EPS 0.11

Volume (Avg. Vol.) 1.21M

Day's Range $11.15 - $11.35

52-Week Range $9.74 - $15.15

Dividend & Yield N/A (N/A)

DVAX Stock Predictions, Articles, and Dynavax Technologies News

The Top 7 Growth Stocks in Biotech

By Alex Sirois, InvestorPlace Contributor Mar 3, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

The 7 Most Undervalued Long-Term Stocks to Buy in January

By Will Ashworth, InvestorPlace Contributor Jan 14, 2023

The undervalued long-term stocks mentioned are a combination of winners and losers from 2022. All are cheap and full of potential upside.

7 Cheap Stocks That Wall Street Analysts Still Love

By Will Ashworth, InvestorPlace Contributor Jan 6, 2023

The number of cheap stocks Wall Street analysts love might have gone down over the past year, but there are still plenty of options.

Our 7 Top Small-Cap Stock Picks for 2023

By Will Ashworth, InvestorPlace Contributor Dec 12, 2022

Most of the names on this list of small-cap stock picks for 2023 are ready to rebound from a tough year in the markets.

3 Under-the-Radar Small-Cap Stocks With 100% Upside Potential

By Will Ashworth, InvestorPlace Contributor Oct 13, 2022

If under-the-radar small-cap stocks are your jam, I’ve got three selections from the S&P SmallCap 600 that might be right up your alley.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 18, 2021

Welcome back, trader! I hope the weekend served you well because we've got pre-market stock movers to start off Monday with!

DVAX Stock: What Is the Covid-19 News Lifting Dynavax Today?

By Chris MacDonald, InvestorPlace Contributor Sep 22, 2021

Today, some impressive vaccine-related news has sent Dynavax and shares of DVAX stock significantly higher as investors pile in.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Sep 13, 2021

The weekend has come and gone and that means it's time to get back into investing with a look at Monday's biggest pre-market stock movers.

7 Penny Stocks to Watch in November

By Divya Premkumar, InvestorPlace Contributor Oct 30, 2020

Penny stocks have become a popular investment alternative in 2020’s volatile corona-economy. Here’s a look at 7 penny stock to watch in November.

Be Careful with Novavax and the Recent Surge in NVAX Stock

By Luke Lango, InvestorPlace Senior Investment Analyst Jun 29, 2020

Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.

7 Great Biotech Stocks to Buy and Hold Now

By Chris Markoch, InvestorPlace Contributor Jun 11, 2020

As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.

7 Red-Hot Vaccine Stocks Racing to Develop a Coronavirus Cure

By Luke Lango, InvestorPlace Senior Investment Analyst May 28, 2020

A race to develop a coronavirus vaccine is on, and these red-hot Covid-19 vaccine stocks are leading the way.

7 “Strong Buy” Stocks With Triple-Digit Growth Prospects

By Maya Sasson, Writer, TipRanks Oct 31, 2019

Investors want to know which stocks are set to take flight. We are talking about stocks with serious growth prospects here, or names that can more than double investors’ returns in the next year.

7 Strong Buy Stocks Analysts Are Upgrading Now, Including Facebook, Inc.

By Harriet Lefton, Writer, TipRanks Jun 13, 2018

Here we dig down into seven intriguing stock rating upgrades from the Street. Why now? Why are analysts turning bullish on these stocks? All seven of these stocks share a 'Strong Buy' analyst consensus rating from the Street. The result: you can be confident that these stocks are the crème de la crème.

Dynavax Technologies (DVAX)

DVAX Stock Earnings: Dynavax Technologies Beats EPS, Misses Revenue for Q2 2024

DVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024

The 7 Best Stocks Under $15 to Buy in June 2023

7 Biotech Stocks Sitting in the Sweet Spot

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Dynavax Technologies (DVAX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DVAX Stock Predictions, Articles, and Dynavax Technologies News

Subscriber Sign in